-+ 0.00%
-+ 0.00%
-+ 0.00%

COMPASS THERAPEUTICS: ENDED Q1 WITH $113 MLN IN CASH AND MARKETABLE SECURITIES, EXPECTED TO PROVIDE CASH RUNWAY INTO Q1 2027

Reuters·05/08/2025 12:00:01

Please log in to view news